media

Markets

Market Nav

News Details

14/02/2024 20:01

Fredun Pharma Q3 net profit up 21.97% at Rs 4.22 cr

The company reported standalone net profit of Rs 4.22 crore for the quarter ended December 31, 2023 as compared to Rs 3.46 crore in the same period last year, registering a year-on-year growth of 21.97 per cent.

Net revenue of the company rose moderately by 11.59 per cent at Rs 86.65 crore in October-December quarter of this fiscal as against Rs 77.65 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 8.27 per cent to Rs 76.49 crore from Rs 70.65 crore in year ago period.

Other Income grew by 12.90 per cent at Rs 0.35 crore versus (Dec'22 Rs 0.31 crore).

Operating Profit surged by 45.14 per cent to Rs 10.16 crore as against Rs 7.00 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 30.19 per cent in December quarter.

Interest grew by 93.33 per cent y-o-y to Rs 3.77 crore, while Taxation increased by 32.76 per cent at Rs 1.54 crore (Dec'22 Rs 1.16 crore).